Related Experiment Video
Updated: May 1, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Impact of depression on circulating endothelial progenitor cells in patients with acute coronary syndromes: a pilot
Rossella Di Stefano1, Francesca Felice, Stefano Pini
1aDepartment of Surgical, Medical and Molecular Pathology and Critic Area bDepartment of Clinical and Experimental Medicine, Psychiatry Sector, University of Pisa, Pisa cUnit of Cardiology, Ospedale S. Andrea, La Spezia dCardio-Respiratory Department, Ospedale Campo di Marte, Lucca eUnit of Cardiology, USL5 Sarzana (SP), Italy *Rossella Di Stefano and Francesca Felice contributed equally to the writing of this article.
Insights
Major depressive episode (MDE) significantly reduces circulating endothelial progenitor cells (EPCs) in acute coronary syndrome (ACS) patients. This suggests MDE impairs the body's natural repair mechanisms following cardiac events, potentially worsening patient outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Cell Biology
Background:
- Depression is a known risk factor for poor prognosis and survival in acute coronary syndrome (ACS) patients.
- Endothelial progenitor cells (EPCs) are crucial for vascular repair and predict clinical outcomes in ACS.
- The relationship between depression and EPC levels in ACS patients requires further investigation.
Purpose of the Study:
- To investigate the impact of major depressive episode (MDE) on the number of circulating endothelial progenitor cells (EPCs) in patients with acute coronary syndrome (ACS).
Main Methods:
- Studied 74 ACS patients (36 with MDE) and control groups.
- Defined and quantified EPCs (CD34CD133KDR) using flow cytometry.
- Conducted standardized cardiological and psychopathological evaluations.
Main Results:
- ACS patients with MDE had significantly lower circulating EPC numbers compared to those without MDE (P < 0.001).
- This reduction in EPCs was observed in both ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) subgroups.
- Results indicate MDE is associated with diminished EPC levels in ACS patients.
Conclusions:
- Major depressive episode is associated with a reduced number of circulating EPCs in ACS patients.
- This suggests that MDE may impair the bone marrow's response to acute ischemic events.
- Reduced EPCs in depressed ACS patients may compromise their reparative capacity and protection, potentially leading to worse clinical outcomes.
Aims:
Depression has been identified as a risk factor for an adverse prognosis and reduced survival in patients with acute coronary syndrome (ACS). The number of endothelial progenitor cells (EPCs) is an independent predictor of clinical outcomes in patients with ACS. The aim of this study was to evaluate the impact of depression on EPC levels in patients with ACS.
Methods:
Out of 74 ACS patients [23 non-ST-segment elevation myocardial infarction (NSTEMI), 48 STEMI], 36 had a diagnosis of major depressive episode (MDE) according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) criteria at the time of the inclusion in the study. Control groups were as follows: 15 healthy individuals and 18 patients with current MDE without a history of cardiovascular diseases. EPCs were defined as CD34CD133KDR and evaluated by flow cytometry. All patients underwent standardized cardiological and psychopathological evaluations. Parametric and nonparametric statistical tests were performed wherever appropriate.
Results:
ACS patients with MDE showed a significant decrease in circulating EPC number compared with ACS patients without MDE (P < 0.001). The ACS study population was then subdivided into STEMI and NSTEMI groups, and within each group patients with MDE again showed a significant decrease in circulating CD34CD133KDR EPCs compared with others (P <0.001).
Conclusion:
We showed that ACS patients with MDE have a reduced number of circulating CD34CD133KDR cells compared with ACS patients without MDE, suggesting that the presence of MDE reduces the response of bone marrow to acute ischemic events. Considering the reparative role of EPCs in ACS patients, we propose that patients with MDE might be protected less than patients without MDE.
More Related Videos
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Coronary Artery Disease II: Pathophysiology